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UNIT 8.2Determination of Binding Thermodynamics
This unit serves as a starting point for exploring the thermodynamic properties of small
molecule–DNA interactions, in theory and practice. The treatment of thermodynamics
here will be limited to determination of simple, apparent association/dissociation con-
stants, a necessary limitation due to the complexity of DNA as a “receptor” and the variety
of different mechanisms by which small molecules recognize DNA sequence, structure,
and dynamics. The spectrum of drug-DNA interactions ranges from sequence specific to
sequence nonselective. For example, the intercalator ethidium bromide is relatively
sequence nonselective in its binding to DNA compared to the enediyne calicheamicin,
which binds to the 3′ ends of purine tracts. For both molecules, the DNA-binding affinity
can be determined on a global scale for a mixture of DNA sequences with a spectrum of
different binding sites. This type of thermodynamic study is useful for defining general
modes of binding such as intercalation, as described in UNIT 8.1, or as a first step in
structure-function studies with ligand congeners. However, the model used to calculate
binding constants must take into account the fact that there is a spectrum of binding sites
with differing affinities for the ligand, and that binding of a ligand molecule to one site
may influence subsequent binding of other ligand molecules (i.e., cooperative interac-
tions).
The basic approach described in this unit consists of data gathering and curve fitting. The
first step in all cases is to determine, under a defined set of conditions, both the
concentration of DNA-bound ligand and the concentration of ligand “free” in solution.
This information can be obtained by any technique that measures a change in some
property of the ligand or DNA that occurs upon binding—including UV/visible (UV/vis)
and fluorescence spectroscopy, circular dichroism, and DNA cleavage analysis—or by a
technique that allows separation of bound and unbound ligand, such as equilibrium
dialysis, centrifugation, or solvent partitioning. Of necessity, this unit will focus on a
single method, spectroscopic titration, to quantify bound and unbound ligand. A binding
constant is then extracted from the data using any of several mathematical models for
DNA-ligand thermodynamics, including the neighbor-exclusion models of McGhee and
von Hippel.
BASIC
PROTOCOL
SPECTROSCOPIC TITRATION OF FIXED DNA CONCENTRATIONS WITH
VARYING LIGAND CONCENTRATIONS
There are several applications in which ligand binding thermodynamics must be deter-
mined in solutions containing many copies of a long (>50 bp) “random” DNA sequences,
such as in the intercalation studies of UNIT 8.1 with plasmid DNA or sonicated calf thymus
DNA. In these cases, the calculation of apparent binding constants is performed with
mathematical models that take into account the possibility of cooperative interactions and
the presence of many sites with differing affinities.
The binding of a ligand to DNA can be assessed by UV/vis or fluorescence spectroscopy
if the ligand possesses optical properties that change upon binding to DNA. Furthermore,
the optical properties must differ from those of DNA, with significant absorbance at
wavelengths >300 nm. Table 8.2.1 contains examples of the optical properties of two
intercalating ligands, ethidium bromide and daunomycin, that can be exploited to deter-
mine DNA binding thermodynamics.
In this protocol, varying ligand concentrations are added to a fixed concentration of DNA
and the absorbance changes are recorded to determine the degree of ligand binding.
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Materials
Assay buffer: 10 mM Tris⋅Cl, HEPES, or other buffer, pH 7, containing 1 mM
EDTA
Calf thymus DNA, sonicated (see recipe)
Ligand of interest dissolved in assay buffer
UV/vis spectrophotometer with temperature-controlled cuvette holder
1-mL cuvette
Software capable of linear regression analysis (e.g., Microsoft Excel)
Additional reagents and equipment for determination of extinction coefficients of
free and DNA-bound ligands (UNIT 8.1, Basic Protocol 3)
Determine extinction coefficients of bound and unbound ligand
1. Using a UV/vis spectrophotometer with temperature-controlled cuvette holder and a
1-mL cuvette, determine the extinction coefficient of the ligand free in solution and
fully bound to DNA as described in UNIT 8.1, Basic Protocol 3.
2. Determine if an isosbestic point exists by examining the absorbance spectra obtained
in step 1 for a wavelength at which the absorbance is the same in the presence and
absence of DNA. Determine the extinction coefficient at the isosbestic wavelength
for a least three different DNA and ligand concentrations (e.g., vary each by a factor
of three).
This value allows calculation of total ligand concentration in the presence of any concen-
tration of DNA.
Perform spectral titrations
3. Blank the spectrophotometer against 1 mL of a 1 mM DNA solution (molarity
calculated as base pairs).
4. Add 1 µL of a 10 mM solution of the ligand and mix thoroughly.
For ligands with extinction coefficients >20,000 M−1cm−1, a 10 M ligand concentration
should provide an absorbance of >0.2, which is adequate for the titration. For ligands with
extinction coefficients <20,000 M−1cm−1, start with higher ligand concentrations (e.g., 50
M). This will ensure an adequate absorbance value for the ligand. Mixing is accomplished
by repeated pipetting or, ideally, on a continuous basis with a stirring bar in spectro-
photometers equipped with a magnetic stirrer.
Table 8.2.1 Optical Properties of Ethidium Bromide and Daunomycin
Property Ethidium bromidea Daunomycinb
λmax free 479 nm 480 nm
λmax bound 517 nm 505 nm
ε480 free 5600-5800 M−1cm−1 11500 M−1cm−1
ε480 bound ∼2500 M−1cm−1 7000 M−1cm−1
Isosbestic pointsc 390 and 510 nm 540 nm (ε = 5100 M−1cm−1)
Relative fluorescenced free = 1; bound ∼15 free = 1; bound = 0.05
aData from Waring, 1965; Hinton and Bode, 1975; Chaires et al., 1982.
bData from Chaires et al., 1982; conditions: 20°C, 6 mM Na2HPO4, 2 mM NaH2PO4, 1 mM Na2EDTA, 185 mM NaCl,
pH 7; calf thymus DNA.
cIsosbestic point: free and bound ligand share the same absorbance at this wavelength.
dFor daunomycin, λem = 555 nm and λex = 480 nm; for ethidium bromide, λem = 605 nm and λex = 525 nm. Values apply
to unbound ligand.
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5. Record the absorbance at the λmax of the ligand or perform a wavelength scan that
encompasses the λmax.
If there is an isosbestic point associated with ligand binding to DNA, then record the
absorbance at this wavelength as well.
6. Repeat steps 4 and 5 for each of three additional 1-µL aliquots of the 10 mM ligand
solution.
7. Repeat steps 3 to 6 for DNA concentrations decreasing in half-log intervals (i.e., 300,
100, 30, . . . µM DNA base pairs) to a final DNA concentration of 1 nM.
The broad range of DNA concentrations ensures a rigorous and complete binding isotherm.
Analyze data
8. Adjust all absorbance values to account for dilution of the sample that occurred upon
addition of each aliquot of ligand.
9. For each aliquot of ligand added to the DNA solution, calculate the total ligand
concentration in solution (Ct), either directly from knowledge of the concentration
of the ligand stock solution or, to avoid pipetting errors, from the absorbance at the
isosbestic wavelength using Beer’s law (i.e., A = εisoslCt, where A is the absorbance,
εisos is the extinction coefficient at the isosbestic wavelength, l is the cuvette path-
length in centimeters, and Ct is the total concentration of the ligand).
10. For each ligand concentration, calculate the concentration of bound ligand (Cb)
according to the following equation:
              Cb = 
εflCt − A
εfl − εbl
             Equation 8.2.1
where A is the absorbance of the solution, εf is the extinction coefficient of the
free (unbound) ligand, εb is the extinction coefficient of the fully bound ligand,
Ct is the total ligand concentration, and l is the pathlength of the cuvette in
centimeters.
This equation is derived from Beer’s law in which the total absorbance is the sum of
contributions from the free and bound ligand: A = εflCf + εblCb. The equation is solved for
Cb by substitution from the equation Ct = Cf + Cb.
11. Calculate Cf according to the following equation:
               Cf = Ct − Cb
              Equation 8.2.2
12. Calculate r, the number of moles of ligand bound per DNA base pair, according to
the following equation:
               r = 
Cb
CDNA
             Equation 8.2.3
where CDNA is the concentration of DNA as base pairs.
13. Plot values of r/Cf versus r for each ligand concentration at each DNA concentration
(i.e., a Scatchard plot).
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If there is no positive cooperativity in the binding of ligand to DNA, the plot should appear
as a downward-sloping curve as demonstrated in Figure 8.2.1. Positive cooperativity will
be apparent as an initial upward slope in the plot followed by a downward-sloping curve.
14. Using any of several software programs that allow nonlinear regression analysis (e.g.,
Microsoft Excel), calculate the apparent binding (association) constant from the r/Cf
and r values according to the neighbor exclusion model of McGhee and von Hippel:
            
r
Cf
 = Kobs(1 − nr)

1 − nr
1 − (n − 1)r

              Equation 8.2.4
where Kobs is the intrinsic (apparent) binding constant (units of M−1) for the ligand
and the DNA species studied, and n is the neighbor exclusion parameter that
represents the size of the ligand binding site in base pairs.
The software should calculate both Kobs and n for the fitted data. One can vary the values
of either n or Kobs and observe the effect of the changes on the standard deviation of thefit. For further information, the reader is referred to the work by Johnson and Faunt (1992),
which provides a general review of least-squares fitting methods.
15. Finally, fit the data to an extended version of the above equation that takes into account
cooperative interactions between ligands:
     
r
Cf
 = Kobs(1 − nr) 

(2ω − 1)(1 − nr) + r − R
s(ω − 1)(1 − nr)

n−1
1 − (n + 1)r + R
2(1 − nr)

2
                Equation 8.2.5
where ω is the cooperativity parameter (ω >1 indicates positive cooperativity and ω
<1 indicates negative cooperativity).
The use of Equation 8.2.5 is justified only if the standard deviation of the fitted line is
smaller than that derived from Equation 8.2.4 or if there is prior knowledge of cooperativity
of the ligand/DNA interaction. If there is little difference between binding constants
obtained by either equation, use the values obtained from Equation 8.2.4.
Figure 8.2.1 Example of a DNA binding isotherm with data fit to the McGhee and von Hippel
equation. Esperamicin A1 is an enediyne antibiotic that intercalates in DNA; esperamicin C is an
analog of A1 missing the intercalating moiety. Adapted with permission from Yu et al. (1994).
Copyright 1994, American Chemical Society.
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REAGENTS AND SOLUTIONS
Use deionized, distilled water in all recipes and protocol steps. For common stock solutions, see
APPENDIX 2A; for suppliers, see SUPPLIERS APPENDIX.
Calf thymus DNA, sonicated
Prepare sonicated calf thymus DNA in assay buffer (10 mM Tris⋅Cl, HEPES, or
other buffer, pH 7, containing 1 mM EDTA) as described in UNIT 8.1, Support
Protocol; use the preparation recommended for Basic Protocol 3 in that unit—i.e.,
10 to 15 min sonication and no size fractionation.
COMMENTARY
Background Information
The experiments in this unit represent just
one of many approaches to quantifying the
DNA binding affinity of a ligand. While the unit
focuses on the use of UV/vis spectroscopy,
virtually any technique can be used as long as
some property of either the DNA or the ligand
changes upon interaction of the two, or the
unbound ligand can be physically separated
from bound ligand. Examples of applicable
techniques include: equilibrium dialysis
(Chaires et al., 1982); fluorescence titration
(Chaires et al., 1982); centrifugation (Minton,
1990; Yu et al., 1994); solvent partitioning
(Waring et al., 1975); and DNA cleavage
(Krishnamurthy et al., 1995).
The calculation of Cf, Cb, and r from data
obtained with these methods is straightforward.
For example, for fluorescent ligands whose fluo-
rescence decreases upon binding to DNA (e.g.,
daunomycin), Cf can be calculated as follows:
Cf = Ct

F − Fmin
F0 − Fmin

Equation 8.2.6
where F is the fluorescence of the ligand in the
presence of some quantity of DNA, Fmin is the
fluorescence of the ligand in the presence of a
large excess of DNA (i.e., fully bound ligand),
and F0 is the fluorescence of the ligand in the
absence of DNA. For a fluorescent ligand
whose fluorescence increases upon binding to
DNA (e.g., ethidium bromide), Cb can be cal-
culated as follows:
Cb = Ct

F − F0
Fmax − F0

Equation 8.2.7
where Fmax is the fluorescence of the ligand in
the presence of a large excess of DNA (i.e., fully
bound ligand). In either case, Cb or Cf is calcu-
lated by difference.
Ideally, the binding data should be acquired
by more than one method, since the physico-
chemical properties of the ligand may affect the
data obtained with different techniques. This is
illustrated in studies performed by Chaires et
al. (1982), in which the binding of daunomycin
to DNA was assessed by solvent partitioning
and spectral titration techniques.
Once the concentrations of bound and free
ligand have been determined, the binding affin-
ity can be quantified by analysis of the ligand-
DNA isotherm. In most cases, a Scatchard plot
of the data (i.e., a plot of r/Cf versus r) will not
produce a straight line as one would expect for
ligand binding to a simple receptor with one or
a few discrete binding sites. Instead, there is
usually a pronounced downward curvature to
the plot, as shown in Figure 8.2.1. The curvature
arises from the binding of one drug molecule
that excludes the binding of other ligand mole-
cules nearby along the DNA polymer, a phe-
nomenon referred to as neighbor exclusion.
Extraction of a binding constant in the face
of the neighbor-exclusion phenomenon can be
achieved by several different numerical analy-
sis methods, the most convenient of which are
the equations derived by McGhee and von Hip-
pel. Equation 8.2.4 is applied to the binding of
a ligand to a DNA lattice of identical, noninter-
acting binding sites. The value n, the exclusion
parameter, describes the size of the binding site
in base pairs and it is best determined with data
approaching saturation of the DNA binding
sites with ligand (Fig. 8.2.2).
However, Equation 8.2.4 does not address
cooperative interactions between ligands. To
account for positive and negative cooperativity
in ligand binding, McGhee and von Hippel
(1974) introduced an additional parameter, ω,
into Equation 8.2.4 to yield Equation 8.2.5. If
ω >1, binding of one ligand molecule will
promote the binding of another ligand nearby
(positive cooperativity), while ω <1 implies
that binding of one ligand molecule will inhibit
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the binding of another molecule nearby (nega-
tive cooperativity). The case of negative coop-
erativity is extremely difficult to distinguish
from the neighbor-exclusion phenomenon, and
the reader is referred to the work of Correia and
Chaires (1994) for approaches to resolving the
contributions of these two features of ligand
binding. Furthermore, the use of the more com-
plicated Equation 8.2.5 can sometimes produce
a poorer fit of the data than Equation 8.2.4. The
best approach is to fit the data to both equations
and compare the standard deviation of the plots.
One can also apply the F test to the resulting
standard deviations to determine the goodness
of fit (Chaires, 1992).
At this point, it is important to discuss the
allosteric binding model of Dattagupta et al.
(1980). This model is more rigorous for small
molecules than the McGhee and von Hippel
model, but it requires greater sophistication in
statistical-mechanical approaches to fitting
data. The McGhee and von Hippel model as-
sumes that the conformation of DNA is not af-
fected by ligand binding and that positive coop-
erativity arises instead from ligand-ligand in-
teractions, such as that occurring between
protein ligands. The allosteric model of Dat-
tagupta et al. (1980), however, takes into account
changes in DNA conformation caused by ligand
binding, which is usually what is occurring. Posi-
tive cooperativity in this model arises when ligand
binding changes DNA conformation in such a way
as to promote binding of other ligands. The only
drawback to the model is that the data cannot be fit
using simple nonlinear regression programs
and instead requires a statistical-mechanical
model to extract the binding constant. Interested
experimentalists are encouraged to explore the
work of Dattagupta et al. (1980).
Further extraction of thermodynamic infor-
mation from the binding isotherms, such as
enthalpy and entropy, is beyond the scope of
this unit. However, one can begin to parse the
contributions made by electrostatic and
nonelectrostatic interactions by measuring the
binding constants in the presence of varying
concentrations of NaCl. For each salt concen-
tration, the apparent binding constant, Kobs, can
be used to calculate the observed Gibbs free
energy (∆Gobs°) from the relation:
∆Gobs°  = −RTlnKobs
Equation 8.2.8
where R is the gas constant and T is the tem-
perature in degrees Kelvin. The ∆Gobs° can be
viewed as the sum of two contributions:
∆Gobs°  = ∆Gnonel + ∆Gel
Equation 8.2.9
where ∆Gnonel and ∆Gel represent the nonelec-
trostatic and electrostatic contributions to free
energy. For several different NaCl concentra-
tions, it has been shown by Record et al. (1978)
that a plot of Kobs versus salt concentration
yields a slope of Zϕ according to the equation:
δlnKobs
δln(Na+)
 = −Zϕ
Equation 8.2.10
where Z is the charge of the ligand, and thus
represents the number of counterions released
during drug binding, and ϕ is the fraction of
Na+ associated with each DNA phosphate. The
electrostatic contribution to the free energy of
ligand binding can then be calculated from:
∆Gel = ZϕRTln(Na+)
Equation 8.2.11
In this way, one can begin to determine the
individual contributions of electrostatic and
nonelectrostatic (e.g., hydrophobic) contribu-
tions to the DNA binding energetics of a ligand.
Critical Parameters
There are several factors critical to the de-
termination of binding constants of small mole-
cules by the technique of spectroscopic titration
Figure 8.2.2 Plot of log(Cf) versus r for the
binding of esperamicin A1 to DNA to demon-
strate completeness of the binding isotherm.
The curve adopts a roughly sigmoidal shape
and becomes nearly asymptotic at low and high
r values, which reflects complete binding and
saturation, respectively. Data adapted from Yu
et al. (1994). 
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described here, and more generally for all meth-
ods used to assess binding thermodynamics.
The most obvious is that the UV/vis absorbance
properties of the ligand must change when the
ligand binds to DNA. A 10% to 15% difference
between the absorbance of bound and unbound
ligand can be considered a minimum for the
rigorous determination of a binding constant.
The ligand should have a λmax > 300 nm to avoid
interference from DNA.
More generally, the titration of ligand and
DNA must be performed over a broad range
of DNA concentrations to ensure a complete
isotherm. The completeness of the binding
isotherm can be assessed by plotting log(Cf)
versus r for the entire set of data. Ideally, the
data will fall on a sigmoidal curve as illus-
trated in Figure 8.2.2 for the enediyne anti-
biotic esperamicin A1. At high r values, the
curve becomes asymptotic due to the satura-
tion of DNA binding sites. Though not illus-
trated well in Figure 8.2.2, the plot becomes
asymptotic at low r values where most of the
ligand is bound to DNA and the Cf becomes
vanishingly small.
Another critical factor is the purity of the
DNA. The presence of contaminating salts,
metals, buffers, proteins, and other molecules
can affect the DNA binding energetics of the
ligand or block binding sites. Ideally, the DNA
should be thoroughly extracted with phe-
nol/chloroform and desalted by dialysis into the
appropriate buffer; alternatively, the extracted
DNA can be purified by gel-filtration chroma-
tography as described in the Support Protocol
in UNIT 8.1.
Troubleshooting
Several problems may be encountered
during the collection of binding data. First,
there may be significant scatter in the data at
the extremes of the binding isotherm due to
systematic errors in determination of the ex-
tinction coefficients and the sensitivity of the
spectrophotometer. It is best to use data in
which the concentration of bound ligand as a
fraction of total ligand concentration is be-
tween 0.2 and 0.8.
Equipment errors may also pose problems.
Sequential additions of ligand should be lim-
ited to only a few aliquots to avoid changes in
absorbance due to drift in the spectrophotome-
ter electronics. Pipetting errors will also intro-
duce significant scatter in the binding data. For
ligands soluble only in organic solvents, the
vapor pressure created during pipetting of
aliquots of the ligand in a volatile solvent can
affect the actual volume of ligand transferred
into the spectrophotometer cuvette. The use of
nonvolatile solvents (e.g., DMSO) or positive-
displacement pipets helps to prevent this prob-
lem. It is also important to use pipets that are
both accurate and precise in the volume range
used in the studies (1 to 10 µL).
Anticipated Results
An example of the anticipated results of
these experiments is shown in the Scatchard
plot in Figure 8.2.1 for the enediyne antibiotics
esperamicins A1 and C. The range of r values
obtained will vary as a function of the binding
affinity of the ligand.
Time Considerations
A complete binding isotherm will require at
least 2 weeks to obtain. The bulk of the time
will be spent preparing reagents such as the
DNA substrate, which must be quite pure to
prevent artifacts from contaminating salts and
proteins. Collection of the binding data by
spectroscopic titration will require ∼1 week,
with the largest fraction of the time spent de-
termining the optimal range of concentrations
of ligand and DNA.
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